开发含有多西环林的生物模拟凝-基亚帕提特复合材料,具有骨质潜在的骨质性潜力
Sandra Daniela Motta1, Pedro Henrique Passos Leite1, Alexia David Nascimento1
1Technological Innovation, ICEX, Universidade Federal de Minas Gerais (UFMG), Av. Antônio Carlos, 6627, Belo Horizonte, Minas Gerais, CEP 31270-901Pampulha, Brazil.
ACS applied bio materials
|July 16, 2025
概括
这项研究开发了用多西环素增强的凝-基亚帕提特复合物,用于骨再生. 这些生物相容材料表现出改善的细胞增殖,抗菌活性和受控的药物释放,为传统骨移植提供了有希望的替代品.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 整形外科的研究研究.
背景情况:
- 骨疾病的发病率不断上升,需要先进的骨移植替代品.
- 生物聚合物提供诸如生物相容性和可用性等优势,但往往缺乏抗菌性质.
- 目前的复合移植材料需要增强抗菌功效,以提高矩阵生物相容性.
研究的目的:
- 开发和评估混合聚合物复合材料,其中包括多西环素,用于增强骨组织再生.
- 评估已开发的支架的细胞兼容性,细胞增殖,粘附和性酸酶 (ALP) 活性.
- 为了研究在体外的药物释放动力学和多西环素增强复合物的酶生物降解.
主要方法:
- 制造凝-氧酸盐-凝 (HA-凝) 支架,与EDC交叉连接,以及不同度的多西环素 (0.3%,0.7%,1.2%).
- 使用L929纤维细胞和MC3T3前骨质细胞评估细胞毒性.
- 在21天后对MC3T3细胞在支架上的细胞增殖,粘附和ALP活性进行评估.
- 对体外药物释放概况和酶生物降解的分析.
主要成果:
- 使用0.3%的多西环素 (1.1) 的支架显示出细胞毒性降低.
- 在21天观察到MC3T3细胞增殖,粘附和ALP活动的显著增加.
- 在体外,药物释放和生物降解率与骨再生时间表一致.
- 添加多西环素增强了抗菌性能,并控制了脚手架的分解.
结论:
- 用多西环素增强的凝-HA复合物在骨组织再生方面表现出极好的生物相容性.
- 开发的材料具有可控的孔隙性,分解性和膨胀性.
- 这些复合材料有效地促进前骨质细胞增殖,提供抗菌活性,并调节药物释放,使它们适合组织工程和药物输送应用.
相关概念视频
01:12Carbon Skeletons
Life on Earth is carbon-based, as all macromolecules that make up living organisms contain carbon atoms. All organic compounds have a carbon backbone. Each carbon atom is tetravalent and can bond with four other atoms, making it an extraordinarily flexible component of biological molecules. Because carbon’s valence electrons are stable, it rarely becomes an ion. As the carbon chain increases in length, structural modifications such as ring structures, double bonds, and branching side chains...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:29Bone Formation by Intramembranous Ossification
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
01:24Bone Formation by Endochondral Ossification
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...